Inari Medical [NARI] vs Globus Medical [GMED] Detailed Stock Comparison
Inari Medical
NASDAQ
Loading...
Globus Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Inari Medical wins in 4 metrics, Globus Medical wins in 12 metrics, with 0 ties. Globus Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Inari Medical | Globus Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2,665.67 | 23.71 | Inari Medical |
| Price-to-Book Ratio | 10.75 | 1.92 | Globus Medical |
| Debt-to-Equity Ratio | 7.53 | 2.83 | Globus Medical |
| PEG Ratio | 571.21 | 0.04 | Globus Medical |
| EV/EBITDA | -176.14 | 11.09 | Inari Medical |
| Profit Margin (TTM) | -13.68% | 13.58% | Globus Medical |
| Operating Margin (TTM) | -4.34% | 17.33% | Globus Medical |
| EBITDA Margin (TTM) | N/A | 17.33% | N/A |
| Return on Equity | -17.72% | 8.62% | Globus Medical |
| Return on Assets (TTM) | -3.21% | 5.82% | Globus Medical |
| Free Cash Flow (TTM) | N/A | $405.21M | N/A |
| 1-Year Return | N/A | -16.03% | N/A |
| Price-to-Sales Ratio (TTM) | 8.15 | 3.15 | Globus Medical |
| Enterprise Value | $4.60B | $8.15B | Globus Medical |
| EV/Revenue Ratio | 8.01 | 3.10 | Globus Medical |
| Gross Profit Margin (TTM) | 87.06% | 66.62% | Inari Medical |
| Revenue per Share (TTM) | $10 | $19 | Globus Medical |
| Earnings per Share (Diluted) | $-1.35 | $2.58 | Globus Medical |
| Beta (Stock Volatility) | 1.03 | 1.20 | Inari Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Inari Medical vs Globus Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Inari Medical | 0.00% | 0.06% | 0.59% | 56.90% | 76.22% | 54.38% |
| Globus Medical | 3.34% | 0.80% | 16.59% | 2.06% | -24.64% | -26.07% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Inari Medical | N/A | N/A | N/A | N/A | N/A | N/A |
| Globus Medical | -16.03% | 0.27% | 7.14% | 144.44% | 348.15% | 348.15% |
Performance & Financial Health Analysis: Inari Medical vs Globus Medical
| Metric | NARI | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $4.68B | $8.26B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,052,478 | 1,846,380 |
| 90 Day Avg. Volume | 3,170,369 | 1,622,753 |
| Last Close | $79.97 | $62.52 |
| 52 Week Range | $36.73 - $79.99 | $51.79 - $94.93 |
| % from 52W High | -0.02% | -34.14% |
| All-Time High | $79.97 (Feb 19, 2025) | $94.93 (Jan 27, 2025) |
| % from All-Time High | 0.00% | -34.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.18% |
| Quarterly Earnings Growth | N/A | 5.39% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.14% |
| Operating Margin (TTM) | -0.04% | 0.17% |
| Return on Equity (TTM) | -0.18% | 0.09% |
| Debt to Equity (MRQ) | 7.53 | 2.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.44 | $31.81 |
| Cash per Share (MRQ) | $1.91 | $1.70 |
| Operating Cash Flow (TTM) | $14.18M | $669.16M |
| Levered Free Cash Flow (TTM) | $86.61M | $456.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inari Medical vs Globus Medical
| Metric | NARI | GMED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2,665.67 | 23.71 |
| Forward P/E | 571.21 | 17.89 |
| PEG Ratio | 571.21 | 0.04 |
| Price to Sales (TTM) | 8.15 | 3.15 |
| Price to Book (MRQ) | 10.75 | 1.92 |
| Market Capitalization | ||
| Market Capitalization | $4.68B | $8.26B |
| Enterprise Value | $4.60B | $8.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.01 | 3.10 |
| Enterprise to EBITDA | -176.14 | 11.09 |
| Risk & Other Metrics | ||
| Beta | 1.03 | 1.20 |
| Book Value per Share (MRQ) | $7.44 | $31.81 |
Financial Statements Comparison: Inari Medical vs Globus Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NARI | GMED |
|---|---|---|
| Revenue/Sales | $153.39M | $598.12M |
| Cost of Goods Sold | $19.85M | $195.40M |
| Gross Profit | $133.54M | $402.72M |
| Research & Development | $29.43M | $33.06M |
| Operating Income (EBIT) | $-6.66M | $98.06M |
| EBITDA | $-304,000 | $160.92M |
| Pre-Tax Income | $-12.67M | $103.67M |
| Income Tax | $5.70M | $28.21M |
| Net Income (Profit) | $-18.37M | $75.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NARI | GMED |
|---|---|---|
| Cash & Equivalents | $41.14M | $461.27M |
| Total Current Assets | $263.39M | $1.71B |
| Total Current Liabilities | $148.78M | $384.70M |
| Long-Term Debt | $31.15M | $81.69M |
| Total Shareholders Equity | $434.76M | $4.09B |
| Retained Earnings | $-122.40M | $1.04B |
| Property, Plant & Equipment | $66.83M | $1.06B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NARI | GMED |
|---|---|---|
| Operating Cash Flow | N/A | $193.84M |
| Capital Expenditures | N/A | $-36.10M |
| Free Cash Flow | N/A | $136.20M |
| Debt Repayment | N/A | $-449.99M |
| Common Stock Repurchase | N/A | $-190.45M |
Short Interest & Institutional Ownership Analysis
| Metric | NARI | GMED |
|---|---|---|
| Shares Short | N/A | 4.78M |
| Short Ratio | N/A | 2.94 |
| Short % of Float | N/A | 0.05% |
| Average Daily Volume (10 Day) | 1,052,478 | 1,846,380 |
| Average Daily Volume (90 Day) | 3,170,369 | 1,622,753 |
| Shares Outstanding | 57.76M | 137.42M |
| Float Shares | 53.34M | 111.73M |
| % Held by Insiders | 0.09% | 0.01% |
| % Held by Institutions | 0.96% | 1.05% |
Dividend Analysis & Yield Comparison: Inari Medical vs Globus Medical
| Metric | NARI | GMED |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |